Loading clinical trials...

Real World Study of Linperlisib for Lymphoma Treatment | Clinical Trials | Clareo Health

Not Yet RecruitingNCT05863871

Real World Study of Linperlisib for Lymphoma Treatment

This is a multicenter, non-interventional and observational real-world study to evaluate the efficacy and safety of linperlisib in patients with lymphoma.

Lead sponsor: Ruijin Hospital•2 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Weili Zhao

CONTACT

+862164370045 [email protected]

Trial snapshot

StatusNOT_YET_RECRUITING

Phase—

Enrollment1,000

Start dateMay 2023

Last updatedMay 18, 2023

Condition

Focus on the Lymphoma Including B/T-cell Lymphoma

Locations shown

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

Shanghai

Tianjin Cancer Hospital/ Tianjin medical university cancer institute & hospital

Tianjin

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 18, 2023Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions